Virtue Diagnostics Indonesia

Virtue Diagnostics Indonesia, established in 2019, is a subsidiary of the Virtue Diagnostics Group, focusing on the in vitro diagnostics (IVD) industry. The company is dedicated to innovation in diagnostic platforms, particularly for emerging markets in Indonesia and Southeast Asia. With a manufacturing facility in Cikarang, Indonesia, the company employs over 60 experts in IVD and research & development. The company provides a range of instruments and reagents for in vitro diagnostics, including biochemistry, chemiluminescence, and molecular technologies. Their technology platforms support clinical solutions for various disease stages, emphasizing infectious diseases, cancer, and chronic diseases. Virtue Diagnostics Indonesia serves healthcare providers and laboratories, aiming to enhance clinical diagnostics in hospitals and research institutions across the region. The company is committed to high-quality production standards, utilizing advanced clean water processing systems and HEPA-filtered air systems in their manufacturing processes.

• Employees 40
• Founded 2022
• Total Funding $100000000